NIH-funded research R01 grant

Creating better methods for producing and editing insulin-producing beta cells

Official title: Development of platforms for sorting, production, editing of beta cells

Funded at Broad Institute, INC. · NIH-11085218 · Data updated 2026-11-12

This study is working on new ways to create and improve insulin-producing beta cells from stem cells, which could help people with type 1 diabetes stop relying on insulin shots or donor transplants, making life easier and healthier for them.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBroad Institute, INC.
NIH-funded
Lab location1 site (Cambridge, United States)
Project startSeptember 5, 2023
Project endApril 30, 2028
Funding year2025
Award (this year)$651,811
NIH project number5R01DK132900-03
Project IDNIH-11085218 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with type 1 diabetes who are currently dependent on insulin therapy.

Less likely to help

Patients with type 2 diabetes or those who do not have diabetes may not benefit from this research.

What this research studies

This research focuses on developing innovative platforms to efficiently sort, produce, and edit beta cells, which are crucial for insulin production in patients with type 1 diabetes. Currently, patients rely on insulin injections or transplants from cadaveric donors, which face challenges like donor scarcity and immune rejection. By utilizing advanced chemical biology and genome engineering techniques, the research aims to create a more reliable and scalable source of beta cells derived from stem cells. This could potentially eliminate the need for lifelong insulin dependence and improve the quality of life for patients.

Why it matters

Potential benefit: If successful, this research could lead to a breakthrough in the treatment of type 1 diabetes by providing a sustainable source of insulin-producing cells.

How similar studies have gone: While there have been advancements in stem cell-derived beta cell research, this specific approach utilizing genome engineering is relatively novel and untested.

Where this research is happening

  • Broad Institute, INC.
    Cambridge, United States
    Active

Researchers

  • Principal investigator: Choudhary, Amit — Broad Institute, INC.
  • Study coordinator: Choudhary, Amit

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.